Carnegie Pharmaceuticals, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 600 Delran Pkwy, Delran, New Jersey (NJ) 08075, United States (USA)
- Operations here
- analysislabelmanufacturepackrelabelrepack
- FDA identifiers
- FEI 3011603634 · DUNS 079839141
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-10-31
- NAIDrug Quality Assurance2021-11-19
Drugs this plant is listed as making
13 distinct drugs across 28 products name this site in their FDA label.
- Aminocaproic AcidCarnegie Pharmaceuticals, LLC
- balsalazide disodiumCarnegie Pharmaceuticals, LLC
- Clindamycin Phosphate TopicalCarnegie Pharmaceuticals, LLC
- EtravirineCarnegie Pharmaceuticals LLC
- FamotidineCarnegie Pharmaceuticals LLC
- Ketorolac Tromethaminein shortageLeading Pharma, LLC
- Liothyronine sodiumBiocon Pharma Inc.
- LomustineCarnegie Pharmaceuticals LLC
- NitrofurantoinBiocon Pharma Inc
- Oseltamivir PhosphateLeading Pharma, LLC
- OxcarbazepineBiocon Pharma Inc.
- PrimidoneCarnegie Pharmaceuticals LLC
- Rasagiline mesylateCarnegie Pharmaceuticals LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.